Rosiglitazone ameliorates senescence and promotes apoptosis in ovarian cancer induced by olaparib
ConclusionsRosiglitazone combined with olaparib can help manage ovarian cancer by ameliorating olaparib-induced senescence and improving anti-tumor effects.
Source: Cancer Chemotherapy and Pharmacology - Category: Cancer & Oncology Source Type: research
More News: Avandia | Cancer | Cancer & Oncology | Chemotherapy | Drugs & Pharmacology | Eye Cancers | Ovarian Cancer | Ovaries | Retinoblastoma | Study